Metagenomi Therapeutics director Eric Bjerkholt was granted stock options for 21,000 shares of common stock at an exercise price of $1.23 per share. T...
Metagenomi Therapeutics, Inc. director Juergen Eckhardt was granted 21,000 stock options with an exercise price of $1.23 per share and an expiration d...
Neutral
Metagenomi CEO Jian Irish sold 3,737 shares of Metagenomi Therapeutics (NASDAQ:MGX) common stock for $4,854 to cover tax withholding obligations relat...
Neutral
Metagenomi Therapeutics (Nasdaq: MGX) announced that its President and CEO, Jian Irish, will participate in a fireside chat at the Jefferies Global He...